Golidocitinib plus CHOP

DRUG2 trials

Sponsors

Peking Union Medical College Hospital, Sun Yat-sen University

Conditions

Peripheral T Cell LymphomaPeripheral T-cell Lymphoma

Phase 1

Golidocitinib Plus CHOP in Newly Diagnosed PTCL

RecruitingNCT06739265

Peking Union Medical College HospitalPeripheral T-cell Lymphoma

Start: 2024-09-01End: 2027-09-01Target: 68Updated: 2024-12-18

Phase 2

Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)

Not yet recruitingNCT07032532

Sun Yat-sen UniversityPeripheral T Cell Lymphoma

Start: 2025-07-31End: 2028-12-31Target: 35Updated: 2025-06-26

Related Papers

Golidocitinib combined with CHOP in newly-diagnosed peripheral T-cell lymphoma: Preliminary Results from A phase 1/2 clinical trial

Blood2025-11-03